nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyzine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.147	0.183	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0399	0.0498	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0391	0.0488	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0336	0.0419	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0329	0.041	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0237	0.0296	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0228	0.0285	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.022	0.0275	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0213	0.0266	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.021	0.0262	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0207	0.0259	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0199	0.0249	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0193	0.0241	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0185	0.0231	CbGpPWpGaD
Hydroxyzine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.0184	0.0928	CrCbGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0179	0.0224	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0176	0.022	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0174	0.0217	CbGpPWpGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0162	0.0202	CbGpPWpGaD
Hydroxyzine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0135	0.0169	CbGpPWpGaD
Hydroxyzine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.0126	0.0635	CrCbGaD
Hydroxyzine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0114	0.0142	CbGpPWpGaD
Hydroxyzine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.011	0.0552	CrCbGaD
Hydroxyzine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0109	0.0136	CbGpPWpGaD
Hydroxyzine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.0106	0.0536	CrCbGaD
Hydroxyzine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.01	0.0506	CrCbGaD
Hydroxyzine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.00889	0.0448	CrCbGaD
Hydroxyzine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.00798	0.0402	CrCbGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00771	0.00962	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00755	0.00942	CbGpPWpGaD
Hydroxyzine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.00752	0.0379	CrCbGaD
Hydroxyzine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0075	0.00936	CbGpPWpGaD
Hydroxyzine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.00742	0.0373	CrCbGaD
Hydroxyzine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.00737	0.0371	CrCbGaD
Hydroxyzine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	0.00682	0.0344	CrCbGaD
Hydroxyzine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.0067	0.0337	CrCbGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0066	0.00824	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00647	0.00807	CbGpPWpGaD
Hydroxyzine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.00563	0.0283	CrCbGaD
Hydroxyzine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	0.00563	0.0283	CrCbGaD
Hydroxyzine—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.00545	0.0274	CrCbGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00523	0.00653	CbGpPWpGaD
Hydroxyzine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	0.00521	0.0262	CrCbGaD
Hydroxyzine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00503	0.00628	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00495	0.00618	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00493	0.00615	CbGpPWpGaD
Hydroxyzine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.00484	0.0244	CrCbGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00483	0.00603	CbGpPWpGaD
Hydroxyzine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.00483	0.0243	CrCbGaD
Hydroxyzine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.0047	0.0237	CrCbGaD
Hydroxyzine—Quetiapine—DRD3—attention deficit hyperactivity disorder	0.0047	0.0237	CrCbGaD
Hydroxyzine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00464	0.0233	CrCbGaD
Hydroxyzine—Quetiapine—DRD1—attention deficit hyperactivity disorder	0.00461	0.0232	CrCbGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00458	0.00571	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00448	0.0056	CbGpPWpGaD
Hydroxyzine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.00437	0.022	CrCbGaD
Hydroxyzine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	0.00435	0.0219	CrCbGaD
Hydroxyzine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	0.00432	0.0218	CrCbGaD
Hydroxyzine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	0.00429	0.0216	CrCbGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00425	0.00531	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00424	0.00529	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00412	0.00514	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00405	0.00505	CbGpPWpGaD
Hydroxyzine—Trazodone—HTR2A—attention deficit hyperactivity disorder	0.004	0.0201	CrCbGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.004	0.00499	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00392	0.00489	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00385	0.0048	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00373	0.00465	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00364	0.00455	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00353	0.0044	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00347	0.00433	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00343	0.00428	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00341	0.00426	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00338	0.00421	CbGpPWpGaD
Hydroxyzine—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.00332	0.0167	CrCbGaD
Hydroxyzine—Quetiapine—DRD2—attention deficit hyperactivity disorder	0.00325	0.0164	CrCbGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00319	0.00398	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00302	0.00377	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00298	0.00372	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00284	0.00355	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00278	0.00347	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00277	0.00346	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00269	0.00335	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00265	0.00331	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00264	0.0033	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00263	0.00328	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00261	0.00326	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00261	0.00326	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00261	0.00326	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00258	0.00322	CbGpPWpGaD
Hydroxyzine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.00256	0.0129	CrCbGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00253	0.00316	CbGpPWpGaD
Hydroxyzine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	0.00251	0.0126	CrCbGaD
Hydroxyzine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00243	0.00303	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00227	0.00284	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00224	0.00279	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00193	0.00241	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00177	0.00221	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00175	0.00219	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0017	0.00212	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00169	0.0021	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00157	0.00196	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00153	0.00191	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.0019	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00152	0.0019	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00149	0.00186	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00149	0.00186	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00147	0.00184	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00146	0.00183	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00142	0.00178	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00138	0.00172	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00137	0.00171	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00169	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00134	0.00167	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00125	0.00156	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00135	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00104	0.00129	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000962	0.0012	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000905	0.00113	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000874	0.00109	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000841	0.00105	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000815	0.00102	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000801	0.000999	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000791	0.000987	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000748	0.000933	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000748	0.000933	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000737	0.000919	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000736	0.000918	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000684	0.000853	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000598	0.000746	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000569	0.00071	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000516	0.000644	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000453	0.000565	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00045	0.000561	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000273	0.000341	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000194	0.000242	CbGpPWpGaD
